B. T. V. van Hagen

Validation of the xylazine/ketamine anesthesia test as a predictor of the emetic potential of pharmacological compounds in rats

J. Prickaerts, B. T. van Hagen, Nick P. van Goethem, 2019, Neuroscience Letters.

Pharmacological depletion of microglia and perivascular macrophages prevents Vascular Cognitive Impairment in Ang II-induced hypertension

H. van Essen, R. Oostenbrugge, J. Prickaerts, 2020, Theranostics.

Pharmacological depletion of microglia prevents vascular cognitive impairment in Ang II-induced hypertension

H. van Essen, R. Oostenbrugge, J. Prickaerts, 2020, bioRxiv.

Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease

Elentina K. Argyrousi, E. Fedele, O. Arancio, 2017, Scientific Reports.

Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor trafficking

Elentina K. Argyrousi, J. Prickaerts, Nick P. van Goethem, 2019, Journal of psychopharmacology.

Assessing spatial pattern separation in rodents using the object pattern separation task

Nick P. van Goethem, Britt T. J. van Hagen, Jos Prickaerts, 2018, Nature Protocols.

New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.

L. Milanesi, E. Fedele, P. Fossa, 2016, European journal of medicinal chemistry.

Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice

R. V. Oostenbrugge, J. Prickaerts, B. Rutten, 2018, Hypertension Research.